antibiotics

GSK
Biotech

GSK's bet on rejected UTI antibiotic pays off with phase 3 win

GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh phase 3 readout.
James Waldron May 28, 2025 8:42am
reshuffle pipeline target reorganize shift change

Spero halts development on another antibiotic

Mar 28, 2025 7:05am
drugs antibiotic

VC firm launches biotech aiming to counter antibiotic resistance

Feb 24, 2025 7:15am
MRSA comeback

Basilea opts not to take MRSA antibiotic into clinic

Feb 18, 2025 4:08am
Front view portrait of young female scientist holding petri dish doing experiments with colored liquid

AI-discovered proteins kill bacteria, fungi infecting mice: study

Feb 7, 2025 2:11pm
Petersburg muskeg peat bog in Alaska

Compounds from bog fungi kill tuberculosis bacteria in the lab

Dec 3, 2024 2:00pm